Cargando…

Retraction notice to “Enhanced IL-17 signalling following myocardial ischaemia/reperfusion injury” [Int. J. Cardiol. 163 (2013) 326–334]

Detalles Bibliográficos
Autores principales: Barry, Seán P., Ounzain, Samir, McCormick, James, Scarabelli, Tiziano M., Chen-Scarabelli, Carol, Saravolatz, Louis I.I., Faggian, Giuseppe, Mazzucco, Alessandro, Suzuki, Hisanori, Thiemermann, Christoph, Knight, Richard A., Latchman, David S., Stephanou, Anastasis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250908/
https://www.ncbi.nlm.nih.gov/pubmed/30449337
http://dx.doi.org/10.1016/j.ijcard.2018.10.031
_version_ 1783373005578043392
author Barry, Seán P.
Ounzain, Samir
McCormick, James
Scarabelli, Tiziano M.
Chen-Scarabelli, Carol
Saravolatz, Louis I.I.
Faggian, Giuseppe
Mazzucco, Alessandro
Suzuki, Hisanori
Thiemermann, Christoph
Knight, Richard A.
Latchman, David S.
Stephanou, Anastasis
author_facet Barry, Seán P.
Ounzain, Samir
McCormick, James
Scarabelli, Tiziano M.
Chen-Scarabelli, Carol
Saravolatz, Louis I.I.
Faggian, Giuseppe
Mazzucco, Alessandro
Suzuki, Hisanori
Thiemermann, Christoph
Knight, Richard A.
Latchman, David S.
Stephanou, Anastasis
author_sort Barry, Seán P.
collection PubMed
description
format Online
Article
Text
id pubmed-6250908
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-62509082019-01-01 Retraction notice to “Enhanced IL-17 signalling following myocardial ischaemia/reperfusion injury” [Int. J. Cardiol. 163 (2013) 326–334] Barry, Seán P. Ounzain, Samir McCormick, James Scarabelli, Tiziano M. Chen-Scarabelli, Carol Saravolatz, Louis I.I. Faggian, Giuseppe Mazzucco, Alessandro Suzuki, Hisanori Thiemermann, Christoph Knight, Richard A. Latchman, David S. Stephanou, Anastasis Int J Cardiol Article Elsevier 2019-01-01 /pmc/articles/PMC6250908/ /pubmed/30449337 http://dx.doi.org/10.1016/j.ijcard.2018.10.031 Text en © 2018 Elsevier Ireland Ltd. All rights reserved. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Article
Barry, Seán P.
Ounzain, Samir
McCormick, James
Scarabelli, Tiziano M.
Chen-Scarabelli, Carol
Saravolatz, Louis I.I.
Faggian, Giuseppe
Mazzucco, Alessandro
Suzuki, Hisanori
Thiemermann, Christoph
Knight, Richard A.
Latchman, David S.
Stephanou, Anastasis
Retraction notice to “Enhanced IL-17 signalling following myocardial ischaemia/reperfusion injury” [Int. J. Cardiol. 163 (2013) 326–334]
title Retraction notice to “Enhanced IL-17 signalling following myocardial ischaemia/reperfusion injury” [Int. J. Cardiol. 163 (2013) 326–334]
title_full Retraction notice to “Enhanced IL-17 signalling following myocardial ischaemia/reperfusion injury” [Int. J. Cardiol. 163 (2013) 326–334]
title_fullStr Retraction notice to “Enhanced IL-17 signalling following myocardial ischaemia/reperfusion injury” [Int. J. Cardiol. 163 (2013) 326–334]
title_full_unstemmed Retraction notice to “Enhanced IL-17 signalling following myocardial ischaemia/reperfusion injury” [Int. J. Cardiol. 163 (2013) 326–334]
title_short Retraction notice to “Enhanced IL-17 signalling following myocardial ischaemia/reperfusion injury” [Int. J. Cardiol. 163 (2013) 326–334]
title_sort retraction notice to “enhanced il-17 signalling following myocardial ischaemia/reperfusion injury” [int. j. cardiol. 163 (2013) 326–334]
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250908/
https://www.ncbi.nlm.nih.gov/pubmed/30449337
http://dx.doi.org/10.1016/j.ijcard.2018.10.031
work_keys_str_mv AT barryseanp retractionnoticetoenhancedil17signallingfollowingmyocardialischaemiareperfusioninjuryintjcardiol1632013326334
AT ounzainsamir retractionnoticetoenhancedil17signallingfollowingmyocardialischaemiareperfusioninjuryintjcardiol1632013326334
AT mccormickjames retractionnoticetoenhancedil17signallingfollowingmyocardialischaemiareperfusioninjuryintjcardiol1632013326334
AT scarabellitizianom retractionnoticetoenhancedil17signallingfollowingmyocardialischaemiareperfusioninjuryintjcardiol1632013326334
AT chenscarabellicarol retractionnoticetoenhancedil17signallingfollowingmyocardialischaemiareperfusioninjuryintjcardiol1632013326334
AT saravolatzlouisii retractionnoticetoenhancedil17signallingfollowingmyocardialischaemiareperfusioninjuryintjcardiol1632013326334
AT faggiangiuseppe retractionnoticetoenhancedil17signallingfollowingmyocardialischaemiareperfusioninjuryintjcardiol1632013326334
AT mazzuccoalessandro retractionnoticetoenhancedil17signallingfollowingmyocardialischaemiareperfusioninjuryintjcardiol1632013326334
AT suzukihisanori retractionnoticetoenhancedil17signallingfollowingmyocardialischaemiareperfusioninjuryintjcardiol1632013326334
AT thiemermannchristoph retractionnoticetoenhancedil17signallingfollowingmyocardialischaemiareperfusioninjuryintjcardiol1632013326334
AT knightricharda retractionnoticetoenhancedil17signallingfollowingmyocardialischaemiareperfusioninjuryintjcardiol1632013326334
AT latchmandavids retractionnoticetoenhancedil17signallingfollowingmyocardialischaemiareperfusioninjuryintjcardiol1632013326334
AT stephanouanastasis retractionnoticetoenhancedil17signallingfollowingmyocardialischaemiareperfusioninjuryintjcardiol1632013326334